Press-release for stocks for astrazeneca plc for GLAXF

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | $140.15 -4.19% 560

| -0.47% | O: 2.1% H: 0.0% C: -2.52%
NVS | News | $92.57 -0.55% 0.0% 910K

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
BAX | News | $39.65 0.33% 0.0% 2.3M

| -0.85% | O: -0.1% H: 0.13% C: -1.08%
ABBV | $164.66 0.25% -0.15% 4.5M

| 1.39% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -1.62% | O: -2.13% H: 0.0% C: 0.0%
BMRN | News S | $90.08 -0.43% -0.43% 940K

| -0.46% | O: -0.72% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $262.77 -0.49% -0.49% 2M

| 0.54% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $140.15 -4.19% 560

| 0.45% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | News | $93.6375 6.88% 82K

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $92.57 -0.55% 0.0% 910K

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.3 0.96% -0.1% 11M

| -9.37% | O: 0.26% H: 2.03% C: 1.57%
ABBV | $164.66 0.25% -0.15% 4.5M

| -9.11% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| -3.69% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -7.26% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 0.01% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $262.77 -0.49% -0.49% 2M

| -6.76% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-03-22 (Crawled : 04:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K

| -13.49% | O: -0.54% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| -3.81% | O: -1.71% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 3.29% | O: 2.67% H: 0.0% C: -1.58%
ALPMY | News | $9.46 -1.11% 500K

| -15.63% | O: 2.26% H: 0.0% C: -2.65%
GSK | $39.27 -0.83% 0.01% 2.2M

| -6.54% | O: 0.4% H: 0.33% C: -0.45%
ABBV | $164.66 0.25% -0.15% 4.5M

| -7.19% | O: 0.16% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 3.13% | O: 0.45% H: 0.53% C: -0.35%
market

Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560

| 1.45% | O: 2.01% H: 0.0% C: -2.01%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -9.3% | O: 1.12% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| -7.74% | O: 0.02% H: 0.79% C: 0.79%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 2.23% | O: 0.9% H: 2.03% C: 1.89%
ABBV | $164.66 0.25% -0.15% 4.5M

| -8.7% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.6% | O: 0.01% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 0.88% | O: -0.19% H: 0.22% C: -0.21%
global set growth market

Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -5.41% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $87.96 3.3% 45K

| -6.8% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | $20.2 -14.18% 510

| -5.92% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | $140.15 -4.19% 560

| 3.19% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | News | $9.46 -1.11% 500K

| -12.05% | O: -1.41% H: 5.06% C: 4.01%
GSK | $39.27 -0.83% 0.01% 2.2M

| -8.21% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| -10.65% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.06% | O: 0.57% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 2.65% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

US Healthcare Advertising Market Analysis Report 2024-2032: A $23.5 Billion Industry in 2023 with Insights on Major Players' Sales and Advertising Spend
Published: 2024-03-09 (Crawled : 04:20) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

| Email alert Add to watchlist
LLY | News | $745.95 -0.64% -0.1% 1.7M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
sales report market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $140.15 -4.19% 560

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $64.07 -4.38% 72K

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.46 -1.11% 500K

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | $13.16 0.08% 0.0% 1.3M

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $92.57 -0.55% 0.0% 910K

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.27 -0.83% 0.01% 2.2M

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.3 0.96% -0.1% 11M

| -5.21% | O: -0.65% H: 1.63% C: 1.48%
ABBV | $164.66 0.25% -0.15% 4.5M

| -7.04% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -2.16% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $262.77 -0.49% -0.49% 2M

| -5.83% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $190.55 -0.84% -0.84% 1.5M

| Email alert Add to watchlist
VTRS | $11.11 0.09% 0.09% 3.5M

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560

| Email alert Add to watchlist
JAZZ | News | $109.3 2.05% 2.01% 560K

| Email alert Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M

| Email alert Add to watchlist
cancer cell global growth market

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49

| 15.8% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | $20.2 -14.18% 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 1.4K

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

Professional, Scientific, and T...

| 9.56% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $57.3 0.02% 33K

| 15.41% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $541.52 -1.05% 0.61% 2.1M

| 1.61% | O: 0.56% H: 1.3% C: 1.22%
TAK | $13.16 0.08% 0.0% 1.3M

| -8.3% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -8.2% | O: -0.91% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| -4.32% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
BAX | News | $39.65 0.33% 0.0% 2.3M

| 0.2% | O: 0.33% H: 0.63% C: -0.28%
ABBV | $164.66 0.25% -0.15% 4.5M

| -6.04% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| -4.13% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -0.13% | O: -1.1% H: 0.0% C: 0.0%
GLPG | News | $28.9 -1.1% -1.11% 140K

| -25.19% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $190.55 -0.84% -0.84% 1.5M

| -13.9% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.36 -0.25% -0.25% 4M

| 11.85% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $262.77 -0.49% -0.49% 2M

| -8.11% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 1.4K

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 9.56% | O: 0.87% H: 0.21% C: -2.23%
GSK | $39.27 -0.83% 0.01% 2.2M

| -4.32% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $393.51 0.1% 0.1% 950K

| -5.51% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -0.13% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M

| -13.9% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.36 -0.25% -0.25% 4M

| 11.85% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $262.77 -0.49% -0.49% 2M

| -8.11% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $140.15 -4.19% 560

| 12.13% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | News | $9.46 -1.11% 500K

| -13.68% | O: 0.37% H: 0.74% C: 0.28%
TAK | $13.16 0.08% 0.0% 1.3M

| -8.11% | O: 0.14% H: 0.35% C: 0.07%
NVS | News | $92.57 -0.55% 0.0% 910K

| -7.41% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -7.56% | O: 0.7% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| -3.58% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.3 0.96% -0.1% 11M

| -2.99% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $164.66 0.25% -0.15% 4.5M

| -5.28% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.2 3.5% 3.38% 690K

| -24.66% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $393.51 0.1% 0.1% 950K

| -6.08% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -0.19% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K

| -6.59% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.82 0.19% 0.19% 1.8M

| -8.85% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $190.55 -0.84% -0.84% 1.5M

| -20.26% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.36 -0.25% -0.25% 4M

| 11.16% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $358.65 -2.06% -2.11% 240K

| -5.61% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $262.77 -0.49% -0.49% 2M

| -9.34% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
GSK | $39.27 -0.83% 0.01% 2.2M

| -5.15% | O: 0.43% H: 0.67% C: 0.21%
BAX | News | $39.65 0.33% 0.0% 2.3M

| -0.03% | O: 0.21% H: 0.24% C: -1.04%
ABBV | $164.66 0.25% -0.15% 4.5M

| -4.15% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -0.9% | O: 1.33% H: 0.0% C: 0.0%
BMRN | News S | $90.08 -0.43% -0.43% 940K

| 1.44% | O: -0.38% H: 1.79% C: 0.22%
AZN | $68.36 -0.25% -0.25% 4M

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $262.77 -0.49% -0.49% 2M

| -15.55% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K

| -16.94% | O: 4.34% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $140.15 -4.19% 560

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
ALPMY | News | $9.46 -1.11% 500K

| -19.27% | O: 0.0% H: 1.38% C: 0.26%
VTRS | $11.11 0.09% 0.09% 3.5M

| -6.01% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $92.57 -0.55% 0.0% 910K

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $164.66 0.25% -0.15% 4.5M

| -0.6% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -8.28% | O: 1.75% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
market

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $140.15 -4.19% 560

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.11 0.09% 0.09% 3.5M

| -6.01% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $92.57 -0.55% 0.0% 910K

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $164.66 0.25% -0.15% 4.5M

| -0.6% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -8.28% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.98 -3.68% -3.82% 290K

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.36 -0.25% -0.25% 4M

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $262.77 -0.49% -0.49% 2M

| -15.16% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -11.05% | O: -1.84% H: 0.52% C: 0.52%
CSLLY | $87.96 3.3% 45K

| -9.68% | O: -0.25% H: 1.0% C: 0.98%
ALPMF | News | $9.594 43.47% 2.2K

| -15.47% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
AZNCF | $140.15 -4.19% 560

| 2.13% | O: 3.1% H: 0.0% C: -3.91%
ALPMY | News | $9.46 -1.11% 500K

| -19.48% | O: -3.53% H: 3.49% C: 3.4%
TVTX | $5.805 -3.09% -3.19% 970K

| -35.73% | O: -1.39% H: 0.16% C: -1.96%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.38% | O: 0.26% H: 0.13% C: -0.18%
AZN | $68.36 -0.25% -0.25% 4M

| 1.6% | O: 0.24% H: 0.01% C: -0.22%
AMGN | $262.77 -0.49% -0.49% 2M

| -14.84% | O: -0.29% H: 0.76% C: 0.67%
companies renal anemia key therapeutics growth market

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | $52.0 6.46% 34K

Consumer Non-Durables

| -27.01% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| -10.09% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | $140.15 -4.19% 560

| 0.3% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | $10.29 -2.05% 1.4M

| -27.38% | O: -0.35% H: 0.07% C: -0.14%
NVS | News | $92.57 -0.55% 0.0% 910K

| -13.6% | O: 0.22% H: 0.43% C: -0.39%
GSK | $39.27 -0.83% 0.01% 2.2M

| 0.81% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| -6.03% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -7.93% | O: 0.92% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 2.27% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published: 2024-01-23 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 0.5% | O: -2.34% H: 0.43% C: 0.43%
AZNCF | $140.15 -4.19% 560

| -0.72% | O: -2.16% H: 1.17% C: 1.17%
NVSEF | News | $93.6375 6.88% 82K

| -13.7% | O: 0.46% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M

| -4.64% | O: 0.17% H: 1.33% C: 0.94%
NVS | News | $92.57 -0.55% 0.0% 910K

| -14.19% | O: -0.96% H: 0.3% C: 0.28%
GSK | $39.27 -0.83% 0.01% 2.2M

| 0.18% | O: -0.76% H: 0.38% C: 0.13%
ABBV | $164.66 0.25% -0.15% 4.5M

| -0.14% | O: 0.37% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| -6.09% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -9.82% | O: -2.05% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 1.68% | O: -1.27% H: 0.8% C: 0.69%
drug hospital infection therapeutics growth market

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 3.48% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| -8.98% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | $140.15 -4.19% 560

| -1.27% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | News | $93.6375 6.88% 82K

| -10.82% | O: -0.24% H: 1.43% C: 1.43%
NVS | News | $92.57 -0.55% 0.0% 910K

| -11.83% | O: 0.32% H: 0.93% C: 0.38%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.36% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -9.61% | O: -0.14% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| -0.75% | O: -0.68% H: 0.87% C: 0.1%
AMGN | $262.77 -0.49% -0.49% 2M

| -11.95% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio
Published: 2023-12-13 (Crawled : 19:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -2.78% | O: 5.56% H: 0.71% C: 0.71%
CSLLY | $87.96 3.3% 45K

| -4.18% | O: 1.46% H: 3.01% C: 0.97%
GLAXF | $20.2 -14.18% 510

| 10.26% | O: 0.58% H: 0.0% C: -1.01%
SNYNF | News | $92.7 -2.18% 1.4K

| -3.35% | O: 0.25% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 4.68% | O: 1.19% H: 3.09% C: 1.3%
GSK | $39.27 -0.83% 0.01% 2.2M

| 7.78% | O: 0.76% H: 1.0% C: -0.11%
BAX | News | $39.65 0.33% 0.0% 2.3M

| 5.5% | O: 1.7% H: 2.44% C: 1.78%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.53% | O: 0.0% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 3.59% | O: 1.21% H: 0.27% C: -0.52%
america vaccine influenza growth market

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 14.06% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | $140.15 -4.19% 560

| 7.6% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $92.57 -0.55% 0.0% 910K

| -4.01% | O: 0.52% H: 0.18% C: -0.43%
GSK | $39.27 -0.83% 0.01% 2.2M

| 9.0% | O: -0.03% H: 0.28% C: -0.41%
BAX | News | $39.65 0.33% 0.0% 2.3M

| 10.89% | O: 0.14% H: 0.78% C: 0.22%
ABBV | $164.66 0.25% -0.15% 4.5M

| 13.39% | O: 0.26% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 6.65% | O: 0.73% H: 0.06% C: -1.38%
AMGN | $262.77 -0.49% -0.49% 2M

| -1.45% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News | $155.97 0.32% 0.32% 19M

Technology Services

| 20.52% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News S | $157.49 0.39% 0.39% 14M

Technology Services

| 20.33% | O: 1.97% H: 0.0% C: 0.0%
ADBE M | $472.91 -0.33% -0.33% 2.4M

Technology Services

| -20.92% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

← Previous
1
2
3
4
5
6
7
8
Next →

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | $1.02 155.0% 57.94% 120M

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M

Commercial Services

INVO | $1.555 104.6% 51.13% 5M

Professional, Scientific, and T...

ISPC | $0.437 105.16% 49.53% 37M

WLGS | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | $6.92 44.17% 30.64% 3.5M